These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity. Prins RM; Incardona F; Lau R; Lee P; Claus S; Zhang W; Black KL; Wheeler CJ J Immunol; 2004 Feb; 172(3):1602-11. PubMed ID: 14734741 [TBL] [Abstract][Full Text] [Related]
25. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Martin B; Hirota K; Cua DJ; Stockinger B; Veldhoen M Immunity; 2009 Aug; 31(2):321-30. PubMed ID: 19682928 [TBL] [Abstract][Full Text] [Related]
26. Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice. Garcia-Hernandez Mde L; Hamada H; Reome JB; Misra SK; Tighe MP; Dutton RW J Immunol; 2010 Apr; 184(8):4215-27. PubMed ID: 20237297 [TBL] [Abstract][Full Text] [Related]
27. Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis. Shitaoka K; Hamana H; Kishi H; Hayakawa Y; Kobayashi E; Sukegawa K; Piao X; Lyu F; Nagata T; Sugiyama D; Nishikawa H; Tanemura A; Katayama I; Murahashi M; Takamatsu Y; Tani K; Ozawa T; Muraguchi A Cancer Immunol Res; 2018 Apr; 6(4):378-388. PubMed ID: 29475880 [TBL] [Abstract][Full Text] [Related]
28. Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer. Kroeger DR; Milne K; Nelson BH Clin Cancer Res; 2016 Jun; 22(12):3005-15. PubMed ID: 26763251 [TBL] [Abstract][Full Text] [Related]
29. Cytotoxic T lymphocytes generated by short-term in vitro TCR stimulation in the presence of IL-4 are therapeutically effective against B16 melanoma. Chang ML; Chen YT; Su YC; Kung JT J Biomed Sci; 2003; 10(6 Pt 1):644-50. PubMed ID: 14576467 [TBL] [Abstract][Full Text] [Related]
30. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077 [TBL] [Abstract][Full Text] [Related]
32. CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes. Huang H; Hao S; Li F; Ye Z; Yang J; Xiang J Immunology; 2007 Feb; 120(2):148-59. PubMed ID: 17274112 [TBL] [Abstract][Full Text] [Related]
33. Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity. Nakagawa H; Sido JM; Reyes EE; Kiers V; Cantor H; Kim HJ Proc Natl Acad Sci U S A; 2016 May; 113(22):6248-53. PubMed ID: 27185917 [TBL] [Abstract][Full Text] [Related]
34. T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells. Li G; Yang Q; Zhu Y; Wang HR; Chen X; Zhang X; Lu B PLoS One; 2013; 8(6):e67401. PubMed ID: 23826287 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of tumor-infiltrating lymphocytes in the treatment of hepatic metastases arising from transgenic intraocular tumors in mice. Ma D; Niederkorn JY Invest Ophthalmol Vis Sci; 1995 May; 36(6):1067-75. PubMed ID: 7730016 [TBL] [Abstract][Full Text] [Related]
36. TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy. Liu S; Etto T; Rodríguez-Cruz T; Li Y; Wu C; Fulbright OJ; Hwu P; Radvanyi L; Lizée G J Immunother; 2010 May; 33(4):371-81. PubMed ID: 20386469 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer. Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800 [TBL] [Abstract][Full Text] [Related]
38. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer. Santin AD; Bellone S; Palmieri M; Bossini B; Cane' S; Bignotti E; Roman JJ; Cannon MJ; Pecorelli S Int J Gynecol Cancer; 2004; 14(1):64-75. PubMed ID: 14764031 [TBL] [Abstract][Full Text] [Related]
39. Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix. Santin AD; Bellone S; Palmieri M; Bossini B; Roman JJ; Cannon MJ; Bignotti E; Canè S; Pecorelli S Gynecol Oncol; 2003 May; 89(2):271-80. PubMed ID: 12713991 [TBL] [Abstract][Full Text] [Related]